Last update 01 Nov 2024
Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc.

Subsidiary Company|
1994|
California, United States
|
50-100
|

Overview

Basic Info

Introduction
Quark was established in 1994 with the aim of creating a groundbreaking technology platform called BiFAR, which is designed to identify novel functional target genes and proteins. This innovative approach involves high throughput gene inactivation combined with microarray detection of the functional genes responsible for the occurrence of phenotypes of interest. With the recent advancements in siRNA technology, Quark's method has become increasingly popular in the industry for functional studies. The company has applied its BiFAR platform in gene discovery programs for serious diseases with significant unmet medical needs, often working with large pharmaceutical partners.

Tags

Nervous System Diseases
Eye Diseases
Otorhinolaryngologic Diseases
siRNA

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
siRNA11
Top 5 TargetCount
caspase 2(Caspase-2)1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
10
1
Phase 3 Clinical
Other
11
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Cosdosiran
( caspase 2 )
Optic Nerve Injuries
More
Phase 3
QPI-1010
Acne Vulgaris
More
Preclinical
AHLi-11
Hearing Disorders
More
Preclinical
QP-AL1
Alopecia
More
Preclinical
QPI-3000R
Hearing Loss
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free